YUCAIPA, Calif., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc.
(Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the
$4B Respiratory market with their Oxyview products for the growing aging
population and emerging markets for Home (DME), Hospital and Aviation industries
announced today that the CEO, Scott Sand, discussed increased profits, margins
and sales at 11:34am eastern daylight time today on The Money Channel's American
Scene Radio with host Steve Crowley.
"The company sales for first quarter had increased more than a 100 times
compared to last year due to the acceptance of the product by the home oxygen
patients and respiratory medical market. Margins of sales were slightly better
than 63%. The future of this company for any investor, compared to other
companies in the market place, is strong and steady," stated Scott R. Sand,
Chief Executive Officer and Chairman of the Board.
The company introduced a new revolutionary product into the medical market this
past June-2009, called the Oxyview Nasal Cannula. Oxyview, the World's First
Patient In-Line Oxygen Flow-Meter, and Oxyview Nasal Cannula, the World's First
Cannula with a built-in oxygen flow meter is another innovative respiratory
product manufactured in the USA by Ingen Technologies; providing more confidence
and assurance to patients who require home oxygen therapy or supplemental
oxygen.
http://www.moneychannel.tv/scas.php
http://www.medcoforum.com/about.php
http://www.chestnet.org/
http://www.copddigest.org/
http://todayssenior.homestead.com/
http://www.mdna.com/shows/medica.html#page=page-1
http://www.arabhealthonline.com/congress/
www.ingen-tech.com
About Ingen: Ingen is an established medical device manufacturer with an
emerging new medical product line for the respiratory market worth an estimated
$4 Billion in the US, and $8 billion globally. The company introduced Oxyview
into the respiratory market in late 2007 after securing US and Foreign Patents
and successful licensing with the Food & Drug Administration, and has commenced
domestic and global distribution with manufacture representative organizations,
and OEM partners. In 2009, the company introduced the new Oxyview Nasal Cannula
for adult, children and infants. In addition to selling its respiratory products
within the global medical industry, the company is selling the same products
within other industries that include aviation, automotive, emergency response,
military and government transportation. The company holds a Device Manufacturing
License with the State of California, Department of Public Health, Food and Drug
Branch as it manufacturers all of its respiratory products in the United States.
There are 32 million US patients with Chronic Obstructive Pulmonary Disease
(COPD), and 600 million patients worldwide. Ingen Technologies is now the
largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes
forward-looking statements. While these statements are made to convey to the
public the company's progress, business opportunities and growth prospects,
readers are cautioned that such forward-looking statements represent
management's opinion. Whereas management believes such representations to be
true and accurate based on information and data available to the company at this
time, actual results may differ materially from those described. The company's
operations and business prospects are always subject to risk and uncertainties.
Important factors that may cause actual results to differ are and will be set
forth in the company's periodic filings with the U.S. Securities and Exchange
Commission.
-0-
CONTACT: Ingen Technologies, Inc.
Jeff Morgan
909-790-7180
www.info@ingen-tech.com
